Literature DB >> 10518213

The structural basis for the recognition of diverse receptor sequences by TRAF2.

H Ye1, Y C Park, M Kreishman, E Kieff, H Wu.   

Abstract

Many members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting TNFR-associated factors (TRAFs) through their cytoplasmic tails. TRAFs apparently recognize highly diverse receptor sequences. Crystal structures of the TRAF domain of human TRAF2 in complex with peptides from the TNFR family members CD40, CD30, Ox40, 4-1BB, and the EBV oncoprotein LMP1 revealed a conserved binding mode. A major TRAF2-binding consensus sequence, (P/S/A/T)x(Q/E)E, and a minor consensus motif, PxQxxD, can be defined from the structural analysis, which encompass all known TRAF2-binding sequences. The structural information provides a template for the further dissection of receptor binding specificity of TRAF2 and for the understanding of the complexity of TRAF-mediated signal transduction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518213     DOI: 10.1016/s1097-2765(00)80334-2

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  99 in total

1.  TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.

Authors:  Aristides G Eliopoulos; Elyse R Waites; Sarah M S Blake; Clare Davies; Paul Murray; Lawrence S Young
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  TRAF family proteins link PKR with NF-kappa B activation.

Authors:  Jesús Gil; Maria Angel García; Paulino Gomez-Puertas; Susana Guerra; Joaquín Rullas; Hiroyasu Nakano; José Alcamí; Mariano Esteban
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

3.  Structure of Sad1-UNC84 homology (SUN) domain defines features of molecular bridge in nuclear envelope.

Authors:  Zhaocai Zhou; Xiulian Du; Zheng Cai; Xiaomin Song; Hongtao Zhang; Takako Mizuno; Emi Suzuki; Marla Rosanne Yee; Alan Berezov; Ramachandran Murali; Shiaw-Lin Wu; Barry L Karger; Mark I Greene; Qiang Wang
Journal:  J Biol Chem       Date:  2011-12-14       Impact factor: 5.157

4.  A novel motif in the Crohn's disease susceptibility protein, NOD2, allows TRAF4 to down-regulate innate immune responses.

Authors:  Jill M Marinis; Craig R Homer; Christine McDonald; Derek W Abbott
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

5.  Comparison of the peptide binding preferences of three closely related TRAF paralogs: TRAF2, TRAF3, and TRAF5.

Authors:  Glenna Wink Foight; Amy E Keating
Journal:  Protein Sci       Date:  2016-02-03       Impact factor: 6.725

6.  The adaptor TRAF5 limits the differentiation of inflammatory CD4(+) T cells by antagonizing signaling via the receptor for IL-6.

Authors:  Hiroyuki Nagashima; Yuko Okuyama; Atsuko Asao; Takeshi Kawabe; Satoshi Yamaki; Hiroyasu Nakano; Michael Croft; Naoto Ishii; Takanori So
Journal:  Nat Immunol       Date:  2014-03-30       Impact factor: 25.606

7.  Structural Insights into mitochondrial antiviral signaling protein (MAVS)-tumor necrosis factor receptor-associated factor 6 (TRAF6) signaling.

Authors:  Zhubing Shi; Zhen Zhang; Zhenzhen Zhang; Yanyan Wang; Chuanchuan Li; Xin Wang; Feng He; Lina Sun; Shi Jiao; Weiyang Shi; Zhaocai Zhou
Journal:  J Biol Chem       Date:  2015-09-18       Impact factor: 5.157

Review 8.  Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.

Authors:  Zuoan Yi; Wai Wai Lin; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-25       Impact factor: 7.638

Review 9.  Function of tumor necrosis factor receptor family members on regulatory T-cells.

Authors:  Robert H Arch
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 10.  Molecular basis of NF-κB signaling.

Authors:  Johanna Napetschnig; Hao Wu
Journal:  Annu Rev Biophys       Date:  2013-03-11       Impact factor: 12.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.